Literature DB >> 22118645

Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet.

Viviane Trak-Smayra1, Valérie Paradis, Julie Massart, Selim Nasser, Victor Jebara, Bernard Fromenty.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the commonest liver diseases in Western countries. Although leptin deficient ob/ob and db/db mice are frequently used as murine models of NAFLD, an exhaustive characterization of their hepatic lesions has not been reported to date, particularly under calorie overconsumption. Thus, liver lesions were characterized in 78 ob/ob and db/db mice fed either a standard or high-calorie (HC) diet, for one or three months. Steatosis, necroinflammation, apoptosis and fibrosis were assessed and the NAFLD activity score (NAS) was calculated. Steatosis was milder in db/db mice compared to ob/ob mice and was more frequently microvesicular. Although necroinflammation was usually mild in both genotypes, it was aggravated in db/db mice after one month of calorie overconsumption. Apoptosis was observed in db/db mice whereas it was only detected in ob/ob mice after HC feeding. Increased apoptosis was frequently associated with microvesicular steatosis. In db/db mice fed the HC diet for three months, fibrosis was aggravated while steatosis, necroinflammation and apoptosis tended to alleviate. This was associated with increased plasma β-hydroxybutyrate suggesting an adaptive stimulation of hepatic mitochondrial fatty acid oxidation (FAO). Nevertheless, one-third of these db/db mice had steatohepatitis (NAS ≥ 5), whereas none of the ob/ob mice developed non-alcoholic steatohepatitis under the same conditions. Steatosis, necroinflammation, apoptosis and fibrosis are modulated by calorie overconsumption in the context of leptin deficiency. Association between apoptosis and microvesicular steatosis in obese mice suggests common mitochondrial abnormalities. Enhanced hepatic FAO in db/db mice is associated with fibrosis aggravation.
© 2011 The Authors. International Journal of Experimental Pathology © 2011 International Journal of Experimental Pathology.

Entities:  

Mesh:

Year:  2011        PMID: 22118645      PMCID: PMC3248077          DOI: 10.1111/j.1365-2613.2011.00793.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  41 in total

1.  Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver?

Authors:  Adam P Levene; Hiromi Kudo; Mark R Thursz; Quentin M Anstee; Robert D Goldin
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

2.  Epidemiology of non-alcoholic fatty liver disease.

Authors:  Stefano Bellentani; Federica Scaglioni; Mariano Marino; Giorgio Bedogni
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

Review 3.  Animal models of non-alcoholic steatohepatitis: of mice and man.

Authors:  J M Schattenberg; P R Galle
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

4.  Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.

Authors:  Anne-Christine Piguet; Deborah Stroka; Arthur Zimmermann; Jean-François Dufour
Journal:  Clin Sci (Lond)       Date:  2009-12-14       Impact factor: 6.124

5.  Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.

Authors:  Antonia Martín-Castillo; Maria Teresa Castells; Gracia Adánez; Maria Teresa Sánchez Polo; Bartolomé García Pérez; Ignacio Ayala
Journal:  Biomed Pharmacother       Date:  2009-10-22       Impact factor: 6.529

6.  Metabolic characterization of a mouse deficient in all known leptin receptor isoforms.

Authors:  Olivia Osborn; Manuel Sanchez-Alavez; Sara E Brownell; Brendon Ross; Joe Klaus; Jeffrey Dubins; Bruce Beutler; Bruno Conti; Tamas Bartfai
Journal:  Cell Mol Neurobiol       Date:  2009-07-07       Impact factor: 5.046

7.  Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.

Authors:  Bernard Fromenty; Nathalie Vadrot; Julie Massart; Bruno Turlin; Nadège Barri-Ova; Philippe Lettéron; Alain Fautrel; Marie-Anne Robin
Journal:  J Pharmacol Exp Ther       Date:  2009-07-08       Impact factor: 4.030

Review 8.  Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications.

Authors:  Elisa Fabbrini; Shelby Sullivan; Samuel Klein
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

9.  Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice.

Authors:  Claudia Mitchell; Marie-Anne Robin; Alicia Mayeuf; Meriem Mahrouf-Yorgov; Abdellah Mansouri; Marie Hamard; Dominique Couton; Bernard Fromenty; Hélène Gilgenkrantz
Journal:  Am J Pathol       Date:  2009-10-01       Impact factor: 4.307

10.  Electron transport chain-dependent and -independent mechanisms of mitochondrial H2O2 emission during long-chain fatty acid oxidation.

Authors:  Erin L Seifert; Carmen Estey; Jian Y Xuan; Mary-Ellen Harper
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

View more
  45 in total

1.  Mouse Models of Liver Fibrosis.

Authors:  Aashreya Ravichandra; Robert F Schwabe
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Authors:  Jennifer H Stern; Joseph M Rutkowski; Philipp E Scherer
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

Review 3.  Effects of Type II Diabetes Mellitus on Tendon Homeostasis and Healing.

Authors:  Anne E C Nichols; Irvin Oh; Alayna E Loiselle
Journal:  J Orthop Res       Date:  2019-06-24       Impact factor: 3.494

4.  Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.

Authors:  Géraldine Gentric; Vanessa Maillet; Valérie Paradis; Dominique Couton; Antoine L'Hermitte; Ganna Panasyuk; Bernard Fromenty; Séverine Celton-Morizur; Chantal Desdouets
Journal:  J Clin Invest       Date:  2015-01-26       Impact factor: 14.808

Review 5.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

6.  Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.

Authors:  Priya Handa; Bryan D Maliken; James E Nelson; Vicki Morgan-Stevenson; Donald J Messner; Barjinderjit K Dhillon; Heather M Klintworth; Mary Beauchamp; Matthew M Yeh; Clinton T Elfers; Christian L Roth; Kris V Kowdley
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 7.  Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?

Authors:  David H Ipsen; Jens Lykkesfeldt; Pernille Tveden-Nyborg
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

8.  XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.

Authors:  Assaf Weiner; Ziv Ben-Ari; Mathias Heikenwälder; Eran Elinav; Ido Amit; Aleksandra Deczkowska; Eyal David; Pierluigi Ramadori; Dominik Pfister; Michal Safran; Baoguo Li; Amir Giladi; Diego Adhemar Jaitin; Oren Barboy; Merav Cohen; Ido Yofe; Chamutal Gur; Shir Shlomi-Loubaton; Sandrine Henri; Yousuf Suhail; Mengjie Qiu; Shing Kam; Hila Hermon; Eylon Lahat; Gil Ben Yakov; Oranit Cohen-Ezra; Yana Davidov; Mariya Likhter; David Goitein; Susanne Roth; Achim Weber; Bernard Malissen
Journal:  Nat Med       Date:  2021-05-20       Impact factor: 53.440

9.  Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice.

Authors:  Oelfah Patel; Christo J F Muller; Elizabeth Joubert; Bernd Rosenkranz; Johan Louw; Charles Awortwe
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

10.  Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJ.

Authors:  Edward H Leiter; Marjorie Strobel; Adam O'Neill; David Schultz; Andrew Schile; Peter C Reifsnyder
Journal:  J Diabetes Res       Date:  2013-04-08       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.